IPP Bureau
Merck KGaA launches ChemiSphere App to digitize lab workflows
By IPP Bureau - December 17, 2025
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
Pfizer cuts 2026 revenue outlook amid COVID-19 & patent losses
By IPP Bureau - December 17, 2025
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
Gujarat Kidney and Super Speciality to file IPO at Rs.108- Rs.114 per share
By IPP Bureau - December 17, 2025
The company operates a chain of mid-sized multi-speciality hospitals
Minghui Pharmaceutical gets FDA green light for Phase III trials of its therapy in thyroid eye disease
By IPP Bureau - December 17, 2025
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
Ascletis Pharma reports positive Phase I results for oral IL-17 inhibitor
By IPP Bureau - December 17, 2025
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
Vanda Pharmaceuticals seeks FDA nod for breakthrough psoriasis drug
By IPP Bureau - December 17, 2025
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
FDA nod to first oral single-dose treatment for gonorrhea
By IPP Bureau - December 16, 2025
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Accenture invests in Ryght AI to revolutionize clinical trials
By IPP Bureau - December 16, 2025
Ryght AI tackles these hurdles with its AI Site Twin platform
FDA accepts Sentynl Therapeutics CUTX-101 NDA resubmission
By IPP Bureau - December 16, 2025
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
By IPP Bureau - December 16, 2025
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
KIMS Hospital Bengaluru commences operations at PES University campus
By IPP Bureau - December 16, 2025
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
Shelter Pharma launches D3 cure capsules
By IPP Bureau - December 16, 2025
This launch is part of the company's strategy to expand its nutraceutical portfolio
Biocon launches its Glucagon-like Peptide-1, Liraglutide, in the Netherlands
By IPP Bureau - December 16, 2025
Godavari Biorefineries ED Sangeeta Srivastava named BRSI Honorary Fellow
By IPP Bureau - December 16, 2025
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
